Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.
about
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.HPTLC-MALDI MS for (glyco)sphingolipid multiplexing in tissues and blood: A promising strategy for biomarker discovery and clinical applications.Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system.Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort StudySerum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis.A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients.Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels.Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.Preanalytical Biases in the Measurement of Human Blood Sphingolipids.
P2860
Q35780081-0B664BA7-02D2-4762-AD0D-9E8CC8BAE24FQ36012933-312A677D-3D1E-4E9A-AA59-74C2C277268DQ36774954-0E96A6A9-EB67-4229-8042-963A52E591EBQ37003642-416AC959-0888-48F1-8FC1-793C77C6D990Q37109693-DEAAF58B-55E3-442A-9E72-765725B7BE97Q37208958-70F43B4D-18EB-4D8D-B829-0B096683E54AQ38833111-67AE4404-B795-40E7-A6A0-49D518A0D484Q39376014-A20E7F19-B7E0-46E3-9A73-7239F4602B28Q40044627-5EF1658F-190C-467D-8AEB-5373038E58F5Q40056735-855828F9-3EB9-4A47-AA15-E92DA1DCF30AQ40700090-BBA15DB8-B9C7-4716-A358-E88F86EE2803Q41200837-59DDDB9B-FB6E-4CCE-9759-1D3A72342B57Q42315013-8CB08E12-984B-4565-BBB5-72B21C6D1918Q53284180-104E0945-0719-4E0C-9F52-74BC2DEA3F58
P2860
Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Variations in serum sphingolip ...... t hepatitis B virus infection.
@en
type
label
Variations in serum sphingolip ...... t hepatitis B virus infection.
@en
prefLabel
Variations in serum sphingolip ...... t hepatitis B virus infection.
@en
P2093
P2860
P356
P1433
P1476
Variations in serum sphingolip ...... t hepatitis B virus infection.
@en
P2093
Caterina Berkowski
Christoph Sarrazin
Daniel Fitting
Dimitra Bon
Eva Herrmann
Georgios Grammatikos
Josef Pfeilschifter
Julia Dietz
Nerea Ferreiros
Stephanie Schwalm
P2860
P304
P356
10.1002/HEP.27587
P407
P577
2015-01-28T00:00:00Z